483Mar 1, 2018

483 Document: Surmasis Pharmaceutical


FDANews 483 Surmasis Pharmaceutical Mar 1 2018 top
Michele L. Obert FDA Investigator Brett R. Havranek FDA Investigator

On Mar 01, 2018, the FDA inspected Surmasis Pharmaceutical's Des Moines site. Explore the inspectional observations.